{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T13:51:17Z","timestamp":1692453077284},"reference-count":46,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2020.11056","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T10:51:51Z","timestamp":1586170311000},"source":"Crossref","is-referenced-by-count":1,"title":["SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in\ufffdvitro and ocular angiogenesis in\ufffdvivo"],"prefix":"10.3892","author":[{"given":"Qiu\u2011Yang","family":"Zhang","sequence":"first","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu\u2011Ya","family":"Tao","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Lu","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing\u2011Jing","family":"Li","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu\u2011Miao","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yao","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Yan","sequence":"additional","affiliation":[{"name":"Eye Institute, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai 200030, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"key20220302131248_b1-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"key20220302131248_b2-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","article-title":"Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy","volume":"26","author":"Zhang","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"key20220302131248_b3-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.brainresbull.2009.05.019","article-title":"Corneal transparency: Genesis, maintenance and dysfunction","volume":"81","author":"Qazi","year":"2010","journal-title":"Brain Res Bull"},{"issue":"pii","key":"key20220302131248_b4-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"BSR20180552","DOI":"10.1042\/BSR20180552","article-title":"Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1\u03b1","volume":"39","author":"Fu","year":"2019","journal-title":"Biosci Rep"},{"key":"key20220302131248_b5-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12041-009-0068-0","article-title":"Mediators of ocular angiogenesis","volume":"88","author":"Qazi","year":"2009","journal-title":"J Genet"},{"key":"key20220302131248_b6-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","article-title":"Horizons in therapy for corneal angiogenesis","volume":"118","author":"Maddula","year":"2011","journal-title":"Ophthalmology"},{"key":"key20220302131248_b7-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.molmed.2014.10.005","article-title":"Seeing through VEGF: Innate and adaptive immunity in pathological angiogenesis in the eye","volume":"21","author":"Sene","year":"2015","journal-title":"Trends Mol Med"},{"key":"key20220302131248_b8-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul Surf"},{"key":"key20220302131248_b9-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2013.01.001","article-title":"Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases","volume":"34","author":"Bock","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"key20220302131248_b10-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0002-9440(10)63216-6","article-title":"Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression","volume":"164","author":"Poulaki","year":"2004","journal-title":"Am J Pathol"},{"key":"key20220302131248_b11-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: Beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"key20220302131248_b12-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ceb.2010.08.010","article-title":"Dynamics of endothelial cell behavior in sprouting angiogenesis","volume":"22","author":"Eilken","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"key20220302131248_b13-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol Rev"},{"key":"key20220302131248_b14-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"key20220302131248_b15-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.coi.2018.05.002","article-title":"Innate effector cells in angiogenesis and lymphangiogenesis","volume":"53","author":"Varricchi","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"key20220302131248_b16-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4149\/neo_2012_062","article-title":"SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy","volume":"59","author":"Shen","year":"2012","journal-title":"Neoplasma"},{"key":"key20220302131248_b17-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/cmdc.200900537","article-title":"Taking quinazoline as a general support-Nog to design potent and selective kinase inhibitors: application to FMS-like tyrosine kinase 3","volume":"5","author":"Li","year":"2010","journal-title":"Chem Med Chem"},{"key":"key20220302131248_b18-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1158\/1078-0432.CCR-10-3109","article-title":"SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo","volume":"17","author":"Zhang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20220302131248_b19-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1111\/aos.13304","article-title":"Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment","volume":"95","author":"Bignami","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"key20220302131248_b20-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nm0909-993","article-title":"Blocking the path of lymphatic vessels","volume":"15","author":"Skobe","year":"2009","journal-title":"Nat Med"},{"key":"key20220302131248_b21-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/156652409789712783","article-title":"Current molecular understanding and future treatment strategies for pathologic ocular neovascularization","volume":"9","author":"Tolentino","year":"2009","journal-title":"Curr Mol Med"},{"key":"key20220302131248_b22-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.survophthal.2017.10.006","article-title":"Gene-based antiangiogenic applications for corneal neovascularization","volume":"63","author":"Liu","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"key20220302131248_b23-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.survophthal.2017.12.008","article-title":"Angiogenesis and lymphangiogenesis in corneal transplantation-A review","volume":"63","author":"Zhong","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"key20220302131248_b24-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1167\/iovs.17-22322","article-title":"Prevention of corneal neovascularization by adenovirus encoding human vascular endothelial growth factor soluble receptor (s-VEGFR1) in lacrimal gland","volume":"59","author":"Nominato","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20220302131248_b25-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.2147\/IJN.S135133","article-title":"Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization","volume":"12","author":"Lee","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"key20220302131248_b26-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: An anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"key20220302131248_b27-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/02713683.2018.1564833","article-title":"Protective effect of TLR4 ablation against corneal neovascularization following chemical burn in a mouse model","volume":"44","author":"Friedman","year":"2019","journal-title":"Curr Eye Res"},{"key":"key20220302131248_b28-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/jama.293.12.1509","article-title":"Inhibitors of ocular neovascularization: Promises and potential problems","volume":"293","author":"van Wijngaarden","year":"2005","journal-title":"JAMA"},{"key":"key20220302131248_b29-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/eye.2011.246","article-title":"Emerging techniques to treat corneal neovascularisation","volume":"26","author":"Menzel-Severing","year":"2012","journal-title":"Eye (Lond)"},{"key":"key20220302131248_b30-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/IJN.S114754","article-title":"Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization","volume":"12","author":"Chang","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"key20220302131248_b31-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.09.001","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"key20220302131248_b32-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2478\/v10042-008-0028-1","article-title":"The effect of tyrosine kinase inhibitors, tyrphostins: AG1024 and SU1498, on autocrine growth of prostate cancer cells (DU145)","volume":"46","author":"Kisielewska","year":"2008","journal-title":"Folia Histochem Cytobiol"},{"key":"key20220302131248_b33-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2013.08.001","article-title":"Role of endothelial cell metabolism in vessel sprouting","volume":"18","author":"De Bock","year":"2013","journal-title":"Cell Metab"},{"key":"key20220302131248_b34-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000320006","article-title":"Mechanisms of ocular angiogenesis and its molecular mediators","volume":"46","author":"Siemerink","year":"2010","journal-title":"Dev Ophthalmol"},{"key":"key20220302131248_b35-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","article-title":"Endothelial cell metabolism in normal and diseased vasculature","volume":"116","author":"Eelen","year":"2015","journal-title":"Circ Res"},{"key":"key20220302131248_b36-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3109\/02713683.2010.502294","article-title":"Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors","volume":"35","author":"Shi","year":"2010","journal-title":"Curr Eye Res"},{"key":"key20220302131248_b37-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrm2183","article-title":"Molecular regulation of angiogenesis and lymphangiogenesis","volume":"8","author":"Adams","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20220302131248_b38-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling-in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20220302131248_b39-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0165-6147(00)01676-X","article-title":"FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition","volume":"22","author":"Cross","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"key20220302131248_b40-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"key20220302131248_b41-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"key20220302131248_b42-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20220302131248_b43-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/BST20110676","article-title":"Roles of p38 MAPKs in invasion and metastasis","volume":"40","author":"del Barco Barrantes","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"key20220302131248_b44-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"key20220302131248_b45-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/1947601913507577","article-title":"Network Motifs in JNK Signaling","volume":"4","author":"Sehgal","year":"2013","journal-title":"Genes Cancer"},{"key":"key20220302131248_b46-mmr-21-06-2571","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim Biophys Acta"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:12:51Z","timestamp":1646219571000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2020.11056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3892\/mmr.2020.11056","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]}}}